Index of reports
> Cases with Neoplasm Progression (7)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Temodar (Temozolomide) where reactions include neoplasm progression. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Temodar side effects in
Reported by a individual with unspecified qualification from United States on 2012-08-25
Patient:
Reactions: Neoplasm Progression
Drug(s) suspected as cause:
Temodar
Other drugs received by patient: Bevacizumab
Possible Temodar side effects in
Reported by a physician from United States on 2012-08-14
Patient:
Reactions: Neoplasm Progression
Drug(s) suspected as cause:
Temodar
Possible Temodar side effects in
Reported by a physician from United States on 2012-08-14
Patient:
Reactions: Neoplasm Progression
Drug(s) suspected as cause:
Temodar
Possible Temodar side effects in
Reported by a physician from United States on 2012-08-10
Patient:
Reactions: Neoplasm Progression
Drug(s) suspected as cause:
Temodar
Possible Temodar side effects in
Reported by a physician from United States on 2012-08-10
Patient:
Reactions: Neoplasm Progression
Drug(s) suspected as cause:
Temodar
Possible Temodar side effects in
Reported by a physician from China on 2012-08-10
Patient:
Reactions: Neoplasm Progression
Drug(s) suspected as cause:
Temodar
Possible Temodar side effects in 44 year old male
Reported by a physician from United States on 2012-05-10
Patient: 44 year old male, weighing 110.0 kg (242.0 pounds)
Reactions: Glioblastoma Multiforme, Pancreatitis Acute, Blood Bilirubin Increased, Blood Pressure Increased, Hyperglycaemia, Blood Albumin Decreased, Neoplasm Progression, Cholelithiasis, Haemoglobin Decreased, Blood Calcium Decreased, Platelet Count Decreased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Avastin
Dosage: 1230 mg;qow;iv ; 1230 mg;qow;iv
Indication: Glioblastoma Multiforme
Start date: 2007-09-10
End date: 2007-10-08
Avastin
Dosage: 1230 mg;qow;iv ; 1230 mg;qow;iv
Indication: Glioblastoma Multiforme
Start date: 2007-10-29
End date: 2007-10-29
Temodar
Dosage: 50 mg/m2;qd;po ; 50 mg/m2;qd;po
Administration route: Oral
Indication: Glioblastoma Multiforme
Start date: 2007-10-29
End date: 2007-11-02
Temodar
Dosage: 50 mg/m2;qd;po ; 50 mg/m2;qd;po
Administration route: Oral
Indication: Glioblastoma Multiforme
Start date: 2007-09-10
End date: 2007-10-13
Other drugs received by patient: Hydrochlorothiazide; Decadron; Diflucan; Baclofen; Flexeril; Colace; Zestril; Nexium; Ambien; Viokase 16; Protonix; Miralax; Xanax; Lexapro; Actigall; Lantus
|